Axsome Therapeutics, Inc. short interest in 2021
In 2021, Axsome Therapeutics, Inc.'s disclosed short interest ran from 8.97% of shares outstanding on 15 Jan 2021 to 9.11% on 31 Dec 2021, a change of +0.14 percentage points. The year's high was 10.64% on 31 Aug 2021 and its low 7.23% on 15 Jul 2021, averaging 8.77% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.76 days on 12 Feb 2021. Full history: Axsome Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 8.97% (15 Jan 2021)
- End of year
- 9.11% (31 Dec 2021)
- Change
- +0.14 pp
- High
- 10.64% (31 Aug 2021)
- Low
- 7.23% (15 Jul 2021)
- Average
- 8.77%
- Highest days to cover
- 13.76 (12 Feb 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 8.97% | 12.59 | |
| 29 Jan 2021 | 9.03% | 11.42 | |
| 12 Feb 2021 | 8.25% | 13.76 | |
| 26 Feb 2021 | 8.61% | 12.54 | |
| 15 Mar 2021 | 8.48% | 10.37 | 10-K filed, results (8-K) |
| 31 Mar 2021 | 7.77% | 9.15 | |
| 15 Apr 2021 | 7.75% | 12.62 | |
| 30 Apr 2021 | 8.31% | 5.93 | |
| 14 May 2021 | 8.68% | 9.61 | 10-Q filed, results (8-K) |
| 28 May 2021 | 9.04% | 10.32 | |
| 15 Jun 2021 | 8.85% | 10.09 | |
| 30 Jun 2021 | 7.72% | 7.70 | |
| 15 Jul 2021 | 7.23% | 7.79 | |
| 30 Jul 2021 | 7.85% | 8.23 | |
| 13 Aug 2021 | 9.02% | 1.34 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 10.64% | 1.77 | |
| 15 Sep 2021 | 8.90% | 2.74 | |
| 30 Sep 2021 | 10.02% | 3.63 | |
| 15 Oct 2021 | 9.99% | 3.63 | |
| 29 Oct 2021 | 8.85% | 5.21 | |
| 15 Nov 2021 | 8.64% | 4.38 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 9.30% | 4.99 | |
| 15 Dec 2021 | 9.57% | 7.25 | |
| 31 Dec 2021 | 9.11% | 7.60 |
See also: Axsome Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.